Document is current
Any future updates will be listed below
-
Authors
Laurichesse, Guillaume
Schwebel, Carole
Buetti, Niccolò
Neuville, Mathilde
Siami, Shidasp
Cohen, Yves
Laurent, Virginie
Mourvillier, Bruno
Reignier, Jean
Goldgran‐Toledano, Dany
Ruckly, Stéphane
de Montmollin, Etienne
Souweine, Bertrand
Timsit, Jean‐François
Dupuis, Claire https://orcid.org/0000-0002-3533-3097
,
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 4 August 2023
Accepted: 12 October 2023
First Online: 30 October 2023
Declarations
:
: In accordance with French law, the OutcomeRea<sup>™</sup> database was approved by the Advisory Committee for Data Processing in Health Research (CCTIRS) and the National Commission for Data Protection and Liberties (CNIL, Registration No. 8999262). The database protocol was submitted to the Institutional Review Board of the Clermont-Ferrand University Hospital, which waived the need for informed consent (IRB No. 5891).
: J.F.T. is a member of scientific advisory boards of Merck, Shionogi, Paratek, Gilead, Pfizer, Becton–Dickinson, and Aspen not related to the submitted work. J.F.T. has given lectures at symposia for Merck, Shionogi, Gilead, Pfizer, and Becton–Dickinson not related to the submitted work. The other authors have no conflicts of interest to declare.
